← Open Payments lookup

KATHERINE KELLY: Open Payments

NPI 1659315315 · COLUMBUS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,206 in 50 payments from 12 companies in 2025. Trend: 2023 $955 · 2024 $849 · 2025 $1,206

Food & beverage: $1,198Education: $8
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.17$461
Vanda Pharmaceuticals Inc.13$293
Neurocrine BioSciences, Inc.6$97
ACADIA Pharmaceuticals Inc1$96
Alkermes, Inc.3$59
Axsome Therapeutics, Inc.2$43
Otsuka America Pharmaceutical, Inc.2$37
E.R. Squibb & Sons, L.L.C.2$30
SUN PHARMACEUTICAL INDUSTRIES INC.1$27
ABBVIE INC.1$26

Products named: UZEDY, FANAPT, INGREZZA, NUPLAZID, AUSTEDO XR, ARISTADA, Auvelity, COBENFY.

Industry payments across IN — which companies pay providers there.